Regulatory Headwinds Challenge Hims & Hers’ Growth Trajectory

Hims & Hers US4330001060

The telehealth sector faces increasing regulatory scrutiny, and Hims & Hers Health, Inc. is making strategic moves to navigate these complex waters. In a significant development, the company has appointed a former senior regulator to a key executive position amid growing pressure from health authorities.

Hims & Hers has named Deb Autor as its first Chief Policy Officer, a strategic hire that brings substantial regulatory expertise to the company’s leadership team. Autor previously served as deputy commissioner of the U.S. Food and Drug Administration and brings three decades of pharmaceutical industry experience, including recent tenure at AstraZeneca.